Study demonstrates ability of the Parsortix system to isolate circulating tumour cells, targeting the metastatic spread of cancer
Liquid biopsy company Angle has announced the results of work undertaken in preclinical models of metastatic breast cancer (MBC), where specific genes involved in the metastatic process have been identified.
